COVID-19 treatment

October 16, 2020

Clinical trial to test HIV drugs to treat COVID-19

Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.

By Bill Snyder
James Crowe Jr., MD, and colleagues are exploring how the body’s immune system gears up to fight off infection.
October 13, 2020

COVID-19 long-acting antibodies discovered by Vanderbilt University Medical Center move to phase 3 clinical trials

AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca.

By Bill Snyder
October 8, 2020

Undiagnosed Diseases Network continues to excel despite pandemic

Though the COVID-19 pandemic halted in-person patient visits at Undiagnosed Diseases Network (UDN) sites, including Vanderbilt University Medical Center’s, since March, groundbreaking behind-the-scenes work continues.

By Nancy Humphrey
September 24, 2020

Cancer centers nationwide join to address the impact of COVID-19 pandemic on cancer prevention and treatment

A consortium of 17 cancer centers in the United States, including Vanderbilt-Ingram Cancer Center, have come together to better understand the consequences of the COVID-19 pandemic in delaying cancer detection, care and prevention.

By VUMC News and Communications
VUMC’s REDCap team helped the Washington State Department of Health ramp up its COVID-19 drive-through testing capabilities. Above, testing is performed in Everett, Washington, in March.
September 24, 2020

REDCap helps state of Washington scale up its testing capacity

Until it was eclipsed by New York in mid-April, the state of Washington had the highest absolute number of COVID-19 cases in the United States.

By Bill Snyder
September 17, 2020

Study finds COVID-19 antibodies drop substantially in the weeks following infection

The antibody levels to SAR-CoV-2, the virus that causes COVID-19, substantially drop in the weeks following infection, according to a study led by Vanderbilt University Medical Center and the Centers for Disease Control and Prevention (CDC).

By Nancy Humphrey
September 7, 2020

Possible key to COVID-19 infectivity

New findings demonstrate how genetic variations in the receptor that binds SARS-CoV-2 impact virus recognition and infectivity and offer insights to COVID-19 susceptibility and treatment.
By Sarah E. Glass
September 3, 2020

MPH students dive in to support COVID-19 response

Graduates from Vanderbilt’s Master in Public Health (MPH) program didn’t plan to become front-line soldiers against the COVID-19 global pandemic, but several have found themselves putting their training — and their career goals — front and center.
By Jake Lowary
September 2, 2020

VUMC launches clinical trial of outpatient treatments for COVID-19

Vanderbilt University Medical Center is now enrolling volunteers for a clinical trial of promising treatments for COVID-19 in the outpatient setting.
By Leigh MacMillan
August 27, 2020

Trial to test nasal irrigation to treat COVID

By Kelsey Herbers
August 21, 2020

VUMC awarded $34 million to lead nationwide convalescent plasma study

Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19.
By Bill Snyder
August 13, 2020

Adaptability, masks, diversity and more takeaways from Leadership Assembly

People are the engine that’s kept Vanderbilt University Medical Center moving forward — and setting the tone for the region on best pandemic mitigation practices — leaders said in a virtual Leadership Assembly, a new channel that is itself reflective of life and work in the pandemic era.
By Holly Fletcher
July 29, 2020

Study finds patients defer routine health care during pandemic

During February and March at two large academic medical centers in Nashville and Boston, screening for high cholesterol and high blood sugar dropped 81-90% and initiation of drug therapy for these conditions dropped 52-60%.
By Paul Govern
1 … 6 7 8 9 10 … 12